当前位置:首页 - 行情中心 - 洁特生物(688026) - 财务分析 - 现金流量表

洁特生物

(688026)

  

流通市值:29.50亿  总市值:29.50亿
流通股本:1.40亿   总股本:1.40亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金297,319,263.97144,608,224.04658,264,170.34491,068,512.69
  收到的税费返还7,982,254.663,033,663.395,162,204.565,163,147.4
  收到其他与经营活动有关的现金20,680,253.067,819,785.636,039,231.6524,739,451.75
  经营活动现金流入小计325,981,771.69155,461,673.03699,465,606.55520,971,111.84
  购买商品、接受劳务支付的现金167,527,582.7484,738,863.28274,107,359.17213,105,003.07
  支付给职工以及为职工支付的现金78,820,018.1533,847,849.31145,098,648.19104,572,683.75
  支付的各项税费16,209,522.6510,107,150.0446,725,633.6736,519,538.93
  支付其他与经营活动有关的现金28,320,365.175,496,647.3241,774,323.6938,477,286.72
  经营活动现金流出小计290,877,488.71134,190,509.95507,705,964.72392,674,512.47
  经营活动产生的现金流量净额35,104,282.9821,271,163.08191,759,641.83128,296,599.37
二、投资活动产生的现金流量:
  收回投资收到的现金612,948,800-587,287,278.37-
  取得投资收益收到的现金1,216,544.03-2,951,247.724,068,840.66
  处置固定资产、无形资产和其他长期资产收回的现金净额--308,567.88-
  收到的其他与投资活动有关的现金20,268,247.45356,065,600426,300,057.29633,627,942.54
  投资活动现金流入小计634,433,591.48356,065,6001,016,847,151.26637,696,783.2
  购建固定资产、无形资产和其他长期资产支付的现金22,620,706.211,222,922.67124,049,648.5975,506,517.84
  投资支付的现金607,003,300-567,287,278.37-
  取得子公司及其他营业单位支付的现金7,762,204.127,762,204.12--
  支付其他与投资活动有关的现金20,442,446.96346,065,600374,090,656.61629,481,729.14
  投资活动现金流出小计657,828,657.28365,050,726.791,065,427,583.57704,988,246.98
  投资活动产生的现金流量净额-23,395,065.8-8,985,126.79-48,580,432.31-67,291,463.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,360,000-890,000-
  其中:子公司吸收少数股东投资收到的现金1,360,000-890,000-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计1,360,000-890,000-
  分配股利、利润或偿付利息支付的现金6,599,085-14,597,348.3415,447,128.34
  其中:子公司支付给少数股东的股利、利润--150,000-
  支付其他与筹资活动有关的现金31,481,005.3118,808,175.441,762,079.89738,625.42
  筹资活动现金流出小计38,080,090.3118,808,175.4416,359,428.2316,185,753.76
  筹资活动产生的现金流量净额-36,720,090.31-18,808,175.44-15,469,428.23-16,185,753.76
四、汇率变动对现金及现金等价物的影响-9,336,091.65-4,843,367.34-2,154,555.921,858,451.38
五、现金及现金等价物净增加额-34,346,964.78-11,365,506.49125,555,225.3746,677,833.21
  加:期初现金及现金等价物余额243,950,502.75243,950,502.75118,395,277.38118,395,277.38
  期末现金及现金等价物余额209,603,537.97232,584,996.26243,950,502.75165,073,110.59
补充资料:
  净利润22,037,218.52-49,094,610.55-
  资产减值准备-14,038-26,572,760.61-
  固定资产和投资性房地产折旧27,882,397.61-52,490,733.76-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧27,882,397.61-52,490,733.76-
  无形资产摊销3,128,153.89-1,560,004.68-
  处置固定资产、无形资产和其他长期资产的损失434,950.88-801,080.79-
  固定资产报废损失165-547,737.17-
  公允价值变动损失---238,219.18-
  财务费用25,560,058.3-30,406,684.34-
  投资损失-1,764,774.95--2,181,291.36-
  递延所得税-787,263.57--3,449,168.33-
  其中:递延所得税资产减少-631,353.57--636.41-
    递延所得税负债增加-155,910--3,448,531.92-
  存货的减少-27,550,045.97--7,233,009.26-
  经营性应收项目的减少3,413,574.7-57,707,008.29-
  经营性应付项目的增加-18,261,460.78--13,399,256.69-
  债务转为资本--1,125-
  不涉及现金收支的投资和筹资活动金额其他项目--1,802,568.13-
  现金的期末余额209,603,537.97-243,950,502.75-
  减:现金的期初余额243,950,502.75-118,395,277.38-
  现金及现金等价物的净增加额-34,346,964.78-125,555,225.37-
公告日期2026-08-312026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑